Skip to content
sellWeak cluster of 410b5-1 plan

Derek J Maetzold sold $289k of CSTL

Pres. & Chief Exec. Officer at CASTLE BIOSCIENCES INC. 9,373 shares at an average of $30.84, traded Nov 4, 2025, filed Nov 6, 2025.

Warning score
39
Value
$289k
9,373 shares
Holdings after
53,615
-15% from before
From 52-week low
+116%
low $14.65, close $31.63
From 52-week high
-6%
high $33.78, as of Nov 4, 2025

Score components

  • Role
    CEO
    +25
  • Trade size
    $289k at market
    +14
  • Share of holdings sold
    Sold 15% of holdings
    +5
  • Cluster
    4 insiders selling within 14 days
    +15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +15.2%, 3m -3.4%, 6m -42.7%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CSTLOct 13, 2026 · close 32.88
Since filing Nov 6, 2025: -2.0%SPY +17.3% · excess -19.3%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001628280-25-050169, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 4, 2025SOpen-market sale
Common Stock10b5-1
-6,458$30.41$196k56,530Nov 6, 2025
Nov 4, 2025SOpen-market sale
Common Stock10b5-1
-237$31.12$7,37556,293Nov 6, 2025
Nov 5, 2025SOpen-market sale
Common Stock10b5-1
-2,678$31.85$85k53,615Nov 6, 2025

Related signals

Other insiders at CASTLE BIOSCIENCES INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
Pro nowfree Oct 21, 2026
CSTLsell 310b5-1
CASTLE BIOSCIENCES INC
Tobin W Juvenal
Chief Commercial Officer
$111k
3,288 shares
-6%
33Weak
CSTLsell 310b5-1
CASTLE BIOSCIENCES INC
Derek J Maetzold
Pres. & Chief Exec. Officer
$516k
14,496 shares
-49%
16Weak
CSTLsell 310b5-1
CASTLE BIOSCIENCES INC
Kristen M Oelschlager
Chief Operating Officer
$149k
4,153 shares
-24%
28Weak
CSTLsell 310b5-1
CASTLE BIOSCIENCES INC
Tobin W Juvenal
Chief Commercial Officer
$232k
6,577 shares
-11%
33Weak
CSTLsell 310b5-1
CASTLE BIOSCIENCES INC
Derek J Maetzold
Pres. & Chief Exec. Officer
$512k
14,496 shares
-48%
27Weak
CSTLsell 310b5-1
CASTLE BIOSCIENCES INC
Tobin W Juvenal
Chief Commercial Officer
$223k
6,600 shares
-10%
32Weak
CSTLsell 310b5-1
CASTLE BIOSCIENCES INC
Derek J Maetzold
Pres. & Chief Exec. Officer
$465k
14,518 shares
-48%
16Weak
CSTLsell 310b5-1
CASTLE BIOSCIENCES INC
Kristen M Oelschlager
Chief Operating Officer
$139k
4,152 shares
-24%
17Weak
CSTLsell 310b5-1
CASTLE BIOSCIENCES INC
Tobin W Juvenal
Chief Commercial Officer
$57k
1,730 shares
-3%
45Moderate
CSTLsell 410b5-1
CASTLE BIOSCIENCES INC
Derek J Maetzold
Pres. & Chief Exec. Officer
$616k
18,560 shares
-55%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Derek J Maetzold sold $289k of CSTL | InsiderTell